Literature DB >> 18621772

Electrical remodelling of the left and right atria due to rheumatic mitral stenosis.

Bobby John1, Martin K Stiles, Pawel Kuklik, Sunil T Chandy, Glenn D Young, Lorraine Mackenzie, Lukasz Szumowski, George Joseph, Jacob Jose, Stephen G Worthley, Jonathan M Kalman, Prashanthan Sanders.   

Abstract

AIMS: To characterize the atrial remodelling in mitral stenosis (MS). METHODS AND
RESULTS: Twenty-four patients with severe MS undergoing commissurotomy and 24 controls were studied. Electrophysiological evaluation was performed in 12 patients in each group by positioning multi-electrode catheters in both atria to determine the following: effective refractory period (ERP) at 10 sites at 600 and 450 ms; conduction time; conduction delay at the crista terminalis (CT); and vulnerability for atrial fibrillation (AF). P-wave duration (PWD) was determined on the surface ECG. In the remaining 12 patients in each group, electroanatomic maps of both atria were created to determine conduction velocity and identify regions of low voltage and electrical silence. Patients with MS had larger left atria (LA) (P < 0.0001); prolonged PWD (P = 0.0007); prolonged ERP in both LA (P < 0.0001) and right atria (RA) (P < 0.0001); reduced conduction velocity in the LA (P = 0.009) and RA (P < 0.0001); greater number (P < 0.0001) and duration (P< 0.0001) of bipoles along the CT with delayed conduction; lower atrial voltage in the LA (P < 0.0001) and RA (P < 0.0001); and more frequent electrical scar (P = 0.001) compared with controls. Five of twelve with MS and none of the controls developed AF with extra-stimulus (P = 0.02).
CONCLUSION: Atrial remodelling in MS is characterized by LA enlargement, loss of myocardium, and scarring associated with widespread and site-specific conduction abnormalities and no change or an increase in ERP. These abnormalities were associated with a heightened inducibility of AF.

Entities:  

Mesh:

Year:  2008        PMID: 18621772     DOI: 10.1093/eurheartj/ehn329

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  36 in total

1.  Association of regional myocardial conduction velocity with the distribution of hypoattenuation on contrast-enhanced perfusion computed tomography in patients with postinfarct ventricular tachycardia.

Authors:  Tuna Ustunkaya; Benoit Desjardins; Bolun Liu; Sohail Zahid; Jaeseok Park; Nissi Saju; Natalia Trayanova; Stefan L Zimmerman; Francis E Marchlinski; Saman Nazarian
Journal:  Heart Rhythm       Date:  2018-10-26       Impact factor: 6.343

2.  Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

Authors:  Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Sohail Zahid; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David Spragg; Hiroshi Ashikaga; Natalia Trayanova; Gordon F Tomaselli; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

Review 3.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

4.  Epicardial Conduction Speed, Electrogram Abnormality, and Computed Tomography Attenuation Associations in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Tuna Ustunkaya; Benoit Desjardins; Riley Wedan; C Anwar A Chahal; Stefan L Zimmerman; Nissi Saju; Sohail Zahid; Apurva Sharma; Yuchi Han; Natalia Trayanova; Francis E Marchlinski; Hugh Calkins; Harikrishna Tandri; Saman Nazarian
Journal:  JACC Clin Electrophysiol       Date:  2019-08-28

Review 5.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 6.  The Role of Atrial Structural Remodeling in Atrial Fibrillation Ablation:An Imaging Point of View for Predicting Recurrence.

Authors:  Yasushi Akutsu; Kaoru Tanno; Youichi Kobayashi
Journal:  J Atr Fibrillation       Date:  2012-08-20

7.  Immediate effect of percutaneous transvenous mitral commissurotomy on atrial electromechanical delay and P-wave dispersion in patients with severe mitral stenosis.

Authors:  Jahangir Rashid Beig; Nisar A Tramboo; Hilal A Rather; Imran Hafeez; Vijai Ananth; Ajaz A Lone; Irfan Yaqoob; Irfan A Bhat; Muzaffar Ali
Journal:  Indian Heart J       Date:  2015-11-21

8.  Prolonged Sinus Pauses upon Termination of Paroxysmal Atrial Fibrillation: Abnormal Right Atrial Electrophysiologic and Electroanatomic Findings.

Authors:  Zhengyu Bao; Hongwu Chen; Bing Yang; Michael Shehata; Weizhu Ju; Fengxiang Zhang; Gang Yang; Kai Gu; Mingfang Li; Kejiang Cao; Xunzhang Wang; Minglong Chen
Journal:  Tex Heart Inst J       Date:  2017-04-01

9.  Long-term outcomes of radiofrequency catheter ablation for atrial fibrillation in rheumatic heart disease patients with mild mitral stenosis.

Authors:  Jindong Chen; Hao Wang; Liang Zhao
Journal:  J Interv Card Electrophysiol       Date:  2019-05-04       Impact factor: 1.900

Review 10.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.